Serum concentrations of C-reactive protein (CRP, a highly specific systemic marker of inflammation) and TNF-α (a powerful pro-inflammatory cytokine) are both associated with an increased risk of developing insulin resistance, type 2 diabetes (T2D), cardiovascular disease (CVD) and cancer [5-8]. Here, CRP is linked to cancer.